Tekla Healthcare Investors

Fundamentals0.0
Price Action5.0
News Sentiment5.0
AI Rating
5.0

Key Drivers

  • Rebound from lows
  • Higher-low pattern
  • Resistance cap

AI
AI Summary

5.0

HQH should be viewed primarily as a high-yield income-and-NAV trade, not a growth story: the discount to NAV offers downside cushion, but with distributions running above earnings/coverage, the key test is whether NAV can hold while the stock clears 20.3 resistance and avoids a break below 19.3.

NAVDiscount
DistributionRisk
TechnicalConfirmation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

0.0

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Rebound from lows
  • Higher-low pattern
  • Resistance cap

Over the last month, HQH has rebounded from the low $19s and formed higher lows, but it remains capped below $20.30 resistance and needs a decisive breakout to confirm momentum.

HQH
rangebound
Support Level: $19.30-$19.50
Resistance Level: $20.30

Failed breakout attempt followed by a pullback below $20.00 after repeated tests of $20.30

Sentiment & News

5.0

Key News Insights:

  • Steady payouts
  • June distribution
  • Capital protection

HQH is being positioned as a steady, income-focused closed-end fund with disciplined variable payouts and a scheduled June distribution that supports capital preservation.

Income
Distributions

The news reinforces HQH's appeal as a predictable income vehicle, with limited immediate impact beyond confirming its next scheduled dividend